Screener
Charles River Laboratories CRL Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| Long-term debt, net and finance leases | 2,619,985 | 2,136,360 |
| Operating lease right-of-use liabilities | 407,708 | 434,048 |
| Deferred tax liabilities | 78,668 | 95,203 |
| Other long-term liabilities | 402,511 | 138,302 |
| Total liabilities | 4,643,618 | 3,924,228 |
| Commitments and contingencies (Notes 2, 12, 14, and 16) | ||
| Redeemable noncontrolling interests | 42,537 | 41,263 |
| Equity: |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's other non-current liabilities?
- Charles River Laboratories (CRL) reported other non-current liabilities of $402.51M in Q2 2026.
- How has Charles River Laboratories's other non-current liabilities changed year-over-year?
- Charles River Laboratories's other non-current liabilities increased by 117.3% year-over-year, from $185.21M to $402.51M.
- What is the long-term trend for Charles River Laboratories's other non-current liabilities?
- Over 5 years (2020 to 2025), Charles River Laboratories's other non-current liabilities has grown at a -7.6% compound annual growth rate (CAGR), from $205.22M to $138.3M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Charles River Laboratories's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude